Showing 1,581 - 1,600 results of 101,229 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.59s Refine Results
  1. 1581

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  2. 1582

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  3. 1583

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  4. 1584

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  5. 1585

    Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

    Published 2023
    “…A machine learning model was developed to identify nonbioavailable substructures based on their molecular properties and shows the accuracy of 83.5%. …”
  6. 1586
  7. 1587

    Decreased MCM2-6 in Drosophila S2 Cells Does Not Generate Significant DNA Damage or Cause a Marked Increase in Sensitivity to Replication Interference by Isabelle Crevel (119003)

    Published 2011
    “…<div><p>A reduction in the level of some MCM proteins in human cancer cells (MCM5 in U20S cells or MCM3 in Hela cells) causes a rapid increase in the level of DNA damage under normal conditions of cell proliferation and a loss of viability when the cells are subjected to replication interference. …”
  8. 1588
  9. 1589

    Vascular Endothelial Growth Factor (VEGF) Bioavailability Regulates Angiogenesis and Intestinal Stem and Progenitor Cell Proliferation during Postnatal Small Intestinal Development by Christopher R. Schlieve (3179439)

    Published 2016
    “…<div><p>Background</p><p>Vascular endothelial growth factor (VEGF) is a highly conserved, master regulatory molecule required for endothelial cell proliferation, organization, migration and branching morphogenesis. …”
  10. 1590
  11. 1591
  12. 1592

    Macroalgae Decrease Growth and Alter Microbial Community Structure of the Reef-Building Coral, <em>Porites astreoides</em> by Rebecca Vega Thurber (41633)

    Published 2012
    “…To determine if macroalgae alter the coral microbiome, we conducted a field-based experiment in which the coral <em>Porites astreoides</em> was placed in competition with five species of macroalgae. …”
  13. 1593
  14. 1594
  15. 1595
  16. 1596

    Data_Sheet_1_Astaxanthin supplementation counters exercise-induced decreases in immune-related plasma proteins.xlsx by David C. Nieman (322662)

    Published 2023
    “…Short-term astaxanthin supplementation (8 mg/day during a 4-week period) provided immune support for runners engaging in a vigorous 2.25 h running bout and uniquely countered decreases in plasma immunoglobulin levels.…”
  17. 1597

    Data_Sheet_2_Astaxanthin supplementation counters exercise-induced decreases in immune-related plasma proteins.xlsx by David C. Nieman (322662)

    Published 2023
    “…Short-term astaxanthin supplementation (8 mg/day during a 4-week period) provided immune support for runners engaging in a vigorous 2.25 h running bout and uniquely countered decreases in plasma immunoglobulin levels.…”
  18. 1598
  19. 1599

    Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite Medicare coverage gap closure by Mugdha Gokhale (8676201)

    Published 2020
    “…<a><b>Objectives</b></a>: <a>Using the 2016 Medicare part D coverage gap as an example, we explored effects of increased out-of-pocket costs on adherence to branded </a>dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients without financial subsidies, relative to subsidized patients who do not experience increased spending during the gap. …”
  20. 1600